What's happening
This bill guarantees ovarian cancer survivors access to genetic and genomic testing without frequency caps or other restrictions.
Why it matters
Ensures ongoing access to advanced genetic and genomic testing for ovarian cancer survivors. , which can be critical for early detection of recurrences, monitoring treatment effectiveness, and identifying potential hereditary cancer risks for family members.
Specifically includes testing for BRCA1, BRCA2, Lynch syndrome, and other relevant mutations. , meaning survivors are guaranteed access to the most relevant and up-to-date screenings tailored to their medical needs.
Removes insurance or provider-imposed limits on the frequency or scope of these tests. , allowing doctors to order tests as often as medically necessary, which can be especially important as new mutations or risks are identified over time.
Empowers healthcare professionals to determine what additional genetic screenings are appropriate. , ensuring that patient care decisions are based on current medical judgment rather than administrative or financial restrictions.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Guarantee Ovarian Cancer Screenings
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Guarantee Cancer Survivor Screenings
In Assembly Committee · Health · Sponsor Roxanne J. Persaud
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
686
2025-2026 Regular Sessions
IN ASSEMBLY (Prefiled)
January 8, 2025
Introduced by M. of A. SOLAGES -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to ensuring ovarian cancer survivors have the right to access screenings for health conditions
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2404-e to read as follows:
§ 2404-e. Ovarian cancer; right to screenings. No person with a personal history of ovarian cancer shall be denied genetic testing or genomic tumor profiling for inherited germline mutations and acquired somatic mutations, respectively. In general, such testing shall not be subject to frequency caps or other limitations and shall include, but not be limited to:
(a) genetic mutations in BRCA1 and BRCA2 genes;
(b) genetic mutations associated with Lynch syndrome;
(c) rearrangement analysis of all coding exons associated with ovarian cancer; and
(d) additional mutations if medically necessary and appropriate, as determined by the health care professional treating the individual.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02193-01-5
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.